New Phase II Mesothelioma Study Showed Notable Results
- Categories:
- Asbestos News
A phase II study combining immunotherapy drugs atezolizumab and bevacizumab showed notable results among peritoneal mesothelioma patients.
By: Rachel Ernst |
By: Rachel Ernst |
By: Rachel Ernst |
By: Rachel Ernst |
By: Rachel Ernst |
By: Destiny Bezrutczyk |
By: Rachel Ernst |
By: Rachel Ernst |
By: Destiny Bezrutczyk |
Mesothelioma Hub is dedicated to helping you find information, support, and advice. Reach out any time!